270 related articles for article (PubMed ID: 36770785)
1. In Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from
Deshpande SH; Muhsinah AB; Bagewadi ZK; Ankad GM; Mahnashi MH; Yaraguppi DA; Shaikh IA; Khan AA; Hegde HV; Roy S
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770785
[TBL] [Abstract][Full Text] [Related]
2. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
3. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
4. Molecular dynamics simulation of bioactive compounds of
Begum S; Shadrack DM; Joseph FM; Ndensendo VMK
J Biomol Struct Dyn; 2022; 40(19):9279-9286. PubMed ID: 34018468
[TBL] [Abstract][Full Text] [Related]
5. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.
Jadaun P; Harshithkumar R; Gaikwad SY; Seniya C; Borse S; Gawai AA; Chavan-Gautam P; Tillu G; Mukherjee A
Virol J; 2023 Aug; 20(1):173. PubMed ID: 37537596
[TBL] [Abstract][Full Text] [Related]
6. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
7. Synthesis,
Gaurav I; Singh T; Thakur A; Kumar G; Rathee P; Kumari P; Sweta K
Curr Pharm Biotechnol; 2020; 21(15):1674-1687. PubMed ID: 32614743
[TBL] [Abstract][Full Text] [Related]
8. Elicitation Approaches for Withanolide Production in Hairy Root Culture of Withania somnifera (L.) Dunal.
Sivanandhan G; Selvaraj N; Ganapathi A; Manickavasagam M
Methods Mol Biol; 2016; 1405():1-18. PubMed ID: 26843160
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
10. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
11. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
13. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
14. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
15. [Hair roots induction and culture of Withania somnifera and its withanolide A synthesis].
Wang FY; Sun YM; Lv CP; Cheng MQ; Zhang L; Sun M
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):790-4. PubMed ID: 25204166
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
17. Leaf spot disease adversely affects human health-promoting constituents and withanolide biosynthesis in Withania somnifera (L.) Dunal.
Singh V; Singh B; Sharma A; Kaur K; Gupta AP; Salar RK; Hallan V; Pati PK
J Appl Microbiol; 2017 Jan; 122(1):153-165. PubMed ID: 27709727
[TBL] [Abstract][Full Text] [Related]
18. Distribution of withaferin A, an anticancer potential agent, in different parts of two varieties of Withania somnifera (L.) Dunal. grown in Sri Lanka.
Siriwardane AS; Dharmadasa RM; Samarasinghe K
Pak J Biol Sci; 2013 Feb; 16(3):141-4. PubMed ID: 24171276
[TBL] [Abstract][Full Text] [Related]
19. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.
Liu X; Chen C; Lin Y; Liu Y; Cai S; Li D; Li L; Xiao P; Yi F
J Ethnopharmacol; 2024 Apr; 323():117699. PubMed ID: 38185262
[TBL] [Abstract][Full Text] [Related]
20. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]